Show pageBacklinksCite current pageExport to PDFFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Studies of these signaling pathways have greatly increased our understanding of the biology and clinical behavior of Glioblastoma. An integrated view of signal transduction will provide a more useful approach in designing novel therapies for this devastating disease. In this review, we summarize the current understanding of Glioblastoma signaling pathways with a focus on potential molecular targets for anti-signaling molecular therapies ((Nakada M, Kita D, Watanabe T, Hayashi Y, Teng L, Pyko IV, Hamada J. Aberrant signaling pathways in glioma. Cancers (Basel). 2011 Aug 10;3(3):3242-78. doi: 10.3390/cancers3033242. PMID: 24212955; PMCID: PMC3759196.)). aberrant_signaling_pathways.txt Last modified: 2025/04/29 20:27by 127.0.0.1